These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1066700)

  • 21. [Clinical correlation of anti-receptor antibody titer, sensitivity to curare and electromyographic changes in experimental autoimmune myasthenia gravis].
    Chen SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):293-6, 320. PubMed ID: 2282884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relation of clinical disease to antibody titre, proliferative response and neurophysiology in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1983 Mar; 51(3):543-50. PubMed ID: 6851245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME
    Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental autoimmune myasthenia gravis and cholinergic ionophore: an electrophysiologic study.
    Takamori M; Mori M; Kasai M
    Neurology; 1979 Jul; 29(7):945-50. PubMed ID: 572943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
    Niks EH; Kuks JB; Wokke JH; Veldman H; Bakker E; Verschuuren JJ; Plomp JJ
    Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine specificity of T cell lines and clones that are capable of inducing autoimmune manifestations in mice.
    Kirshner SL; Katz-Levy Y; Wirguin I; Argov Z; Mozes E
    Cell Immunol; 1994 Aug; 157(1):11-28. PubMed ID: 7518748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis.
    Berman PW; Patrick J
    J Exp Med; 1980 Sep; 152(3):507-20. PubMed ID: 6774045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological studies of acetylcholine receptors.
    Lindstrom J
    J Supramol Struct; 1976; 4(3):389-403. PubMed ID: 817087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice.
    Berman PW; Heinemann SF
    J Immunol; 1984 Feb; 132(2):711-7. PubMed ID: 6690616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.
    Gomez CM; Richman DP
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4089-93. PubMed ID: 6575398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies.
    Tzartos SJ; Seybold ME; Lindstrom JM
    Proc Natl Acad Sci U S A; 1982 Jan; 79(1):188-92. PubMed ID: 6948300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to gallamine: an indicator of diminished neuromuscular function in experimental autoimmune myasthenia gravis.
    Hinman CL; Dambach GE; Hudson RA; Rauch HC
    J Neurosci Res; 1985; 14(2):271-8. PubMed ID: 4046075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis: passive transfer from man to mouse.
    Toyka KV; Brachman DB; Pestronk A; Kao I
    Science; 1975 Oct; 190(4212):397-9. PubMed ID: 1179220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.
    Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
    Exp Neurol; 2012 Oct; 237(2):286-95. PubMed ID: 22789393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain differences in the autoimmune response of mice to acetylcholine receptors.
    Fuchs S; Nevo D; Tarrab-Hazdai R; Yaar I
    Nature; 1976 Sep; 263(5575):329-30. PubMed ID: 1085423
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis.
    Noguchi SA; Drachman DB; Adams RN; Hirsch RL
    Ann Neurol; 1980 Jul; 8(1):32-7. PubMed ID: 7406445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.